SEC Form 4 · accession 0001093557-18-000222

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Strategy & Corp. Dev.

Period of report

Oct 23, 2018

Accepted (ET)

Oct 25, 2018 · 8:58 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001093557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Oct 23, 2018	S	2,014	$128.6102	D	111,846	D
Common Stock^F1,F4,F3	Oct 23, 2018	S	1,100	$129.3023	D	110,746	D

No Table II lines on this filing.

F1On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2This transaction was executed in multiple trades at prices ranging from $128.06 to $129.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.
F4This transaction was executed in multiple trades at prices ranging from $129.06 to $129.78. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.